Cell line name |
DM319 |
Synonyms |
Duke Melanoma 319 |
Accession |
CVCL_6625 |
Resource Identification Initiative |
To cite this cell line use: DM319 (RRID:CVCL_6625) |
Comments |
From: Duke University Medical Center; Durham; USA. |
Disease |
Melanoma (NCIt: C3224) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Sex unspecified |
Age at sampling |
Age unspecified |
Category |
Cancer cell line |
Publications | PubMed=9241074; DOI=10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U Zeinab Abdel-Wahab, Christina Weltz, Dina Hester, Nancy Pickett, Carol Vervaert, Jack R. Barber, Douglas J. Jolly, Hilliard Foster Seigler; A phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response. Cancer 80:401-412(1997) PubMed=11520076; DOI=10.1006/cimm.2001.1809 Rahima Zennadi, Zeinab Abdel-Wahab, Hilliard Foster Seigler, Timothy L. Darrow; Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells. Cell. Immunol. 210:96-105(2001) PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209 Kevin T. Hogan, Michael A. Coppola, Christine L. Gatlin, Lee W. Thompson, Jeffrey Shabanowitz, Donald Frederick Hunt, Victor H. Engelhard, Mark M. Ross, Craig L. Slingluff Jr.; Identification of novel and widely expressed cancer/testis gene isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to melanoma. Cancer Res. 64:1157-1163(2004) |
Cross-references |
Encyclopedic resources |
Wikidata; Q54831214
|
Entry history |
Entry creation | 04-Apr-2012 |
Last entry update | 14-Aug-2025 |
Version number | 12 |
---|